Ovid Therapeutics (OVID) Q1 2025 Earnings

Mar 11Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.22
-0.11
0.01
0.12

Details

Expected EPS
-0.168682
Actual EPS
-0.13
Surprise EPS
0.04
Surprise Percent
+22.93%

Description

⁨Ovid Therapeutics⁩ (⁦OVID⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts